Diamond Biofund Inc. (TPE:6901)
Taiwan · Delayed Price · Currency is TWD 16.15
-0.40 (-2.42%)
Aug 28, 2026, 1:30 PM CST
Diamond Biofund Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 13,782 | 14,058 | 27,810 | 41,446 | 48,069 | - | |
Market Cap Growth | -23.33% | -49.45% | -32.90% | -13.78% | - | - |
Enterprise Value | 6,640 | 9,882 | 21,935 | 29,518 | 37,521 | - |
Last Close Price | 16.15 | 16.50 | 32.70 | 48.80 | 64.00 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 4.77 | - | - | - | 60.25 | - |
PS Ratio | 4.56 | -13.10 | -12.48 | -16.99 | 47.33 | - |
PB Ratio | 1.12 | 1.53 | 2.68 | 3.22 | 4.35 | - |
P/TBV Ratio | 1.12 | 1.53 | 2.68 | 3.22 | 4.35 | - |
P/FCF Ratio | - | - | 24.72 | - | 101.92 | - |
P/OCF Ratio | - | - | 24.41 | - | 101.61 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.20 | - | - | - | 36.94 | - |
EV/EBITDA Ratio | 2.29 | - | - | - | 41.53 | - |
EV/EBIT Ratio | 2.31 | - | - | - | 41.59 | - |
EV/FCF Ratio | - | - | 19.50 | - | 79.56 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.00 |
Debt / EBITDA Ratio | 0.03 | - | - | - | 0.00 | 0.01 |
Debt / FCF Ratio | - | - | 0.11 | - | 0.01 | - |
Net Debt / Equity Ratio | -0.58 | -0.41 | -0.48 | -0.74 | -0.97 | -0.97 |
Net Debt / EBITDA Ratio | -2.48 | 3.13 | 2.09 | 3.67 | -11.88 | -3.36 |
Net Debt / FCF Ratio | 24.56 | 14.37 | -4.46 | 3.68 | -22.76 | 33.44 |
Asset Turnover | 0.28 | - | - | - | 0.09 | 0.31 |
Quick Ratio | 104.24 | 56.87 | 24.75 | 146.29 | 74.55 | 51.07 |
Current Ratio | 104.29 | 56.91 | 24.76 | 146.38 | 74.56 | 51.07 |
Return on Equity (ROE) | 26.97% | -11.99% | -21.67% | -21.61% | 7.44% | 29.26% |
Return on Assets (ROA) | 16.38% | -7.62% | -12.70% | -13.40% | 5.17% | 18.79% |
Return on Invested Capital (ROIC) | 55.39% | -22.65% | -55.36% | -141.94% | 246.54% | 203.34% |
Return on Capital Employed (ROCE) | 23.30% | -13.10% | -23.00% | -20.00% | 8.20% | 28.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 21.22% | -8.36% | -9.05% | -6.23% | 1.66% | - |
FCF Yield | -2.11% | -1.88% | 4.04% | -6.24% | 0.98% | - |
Dividend Yield | - | - | - | - | 0.27% | - |
Payout Ratio | - | - | - | - | 18.80% | - |
Buyback Yield / Dilution | -1.17% | -0.18% | -9.19% | -1.21% | 4.90% | -18.16% |
Total Shareholder Return | -1.17% | -0.18% | -9.19% | -1.21% | 5.16% | -18.16% |